References
- GehrsKMAndersonDHJohnsonLVHagemanGSAge-related macular degeneration – emerging pathogenetic and therapeutic conceptsAnn Med200638745047117101537
- SalminenAKauppinenAHyttinenJMToropainenEKaarnirantaKEndoplasmic reticulum stress in age-related macular degeneration: trigger for neovascularizationMol Med20101611–1253554220683548
- KaarnirantaKSalminenAHaapasaloASoininenHHiltunenMAge-related macular degeneration (AMD): Alzheimer’s disease in the eye?J Alzheimers Dis201124461563121297256
- ChakravarthyUHardingSPRogersCAfor IVAN Study InvestigatorsRanibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trialOphthalmology201211971399141122578446
- MartinDFMaguireMGYingGSfor CATT Research GroupRanibizumab and bevacizumab for neovascular age-related macular degenerationN Engl J Med2011364201897190821526923
- KoKFThe role of evoked potential and MR imaging in assessing multiple sclerosis: a comparative studySingapore Med J201051971672020938612
- RosenfeldPJBrownDMHeierJSfor MARINA Study GroupRanibizumab for neovascular age-related macular degenerationN Engl J Med2006355141419143117021318
- PaiSAShettyRVijayanPBClinical, anatomic, and electrophysiologic evaluation following intravitreal bevacizumab for macular edema in retinal vein occlusionAm J Ophthalmol2007143460160617306753
- WolffBEBearseMAJrSchneckMEBarezSAdamsAJMultifocal VEP (mfVEP) reveals abnormal neuronal delays in diabetesDoc Ophthalmol2010121318919620737191
- KarlicaDGaletovićDBućanKZnaorLRetinoscopy and visual evoked potential based evaluation of the exactness of hyperopia correction in children with developmental difficultiesActa Clin Croat201049325125521462813
- MackyTAMahgoubMMElectrophysiological assessment of optic nerve and retinal functions following intravitreal injection of bevacizumab (avastin)J Ocul Pharmacol Ther201228215916522149483
- LiuYWenFLiJZuoCLiMTransitions of multifocal electroretinography in patients with age-related macular degeneration after combination therapy with photodynamic therapy and intravitreal bevacizumabDoc Ophthalmol2009119316316920101800